Zuber Lawler & Del Duca
Strategic Legal Solutions for Visionary Clients
구성원
Experience. Judgment. Passion.
Josh Lawler
파트너 변호사 파트너 변호사
Mr. Lawler 에게 이메일 보내기 vCard Printable Biography Connect on LinkedIn®
경력
- 전문분야: 엔터테인먼트, 법인법, 증권법
- Skadden, Arps, Slate, Meaghar & Flom LLP, 변호사
- 참여한 대표적인 케이스: 1억 천만 달러 상당의 고수익 어음거래, 1억 달러 상당의 회사 주식공모, 2억 5천만 달러 상당 차입 자본 이용 기업매수 (LBO 식 기업 매수), 1억 3천만 달러 상당 기업매수
- Zuber Lawler & Del Duca LLP 파트너 변호사 (현재)
주요저서
- ”Intellectual Property Protection of Animation Derivative Products in the U.S.” China IP Magazine (September / October 2009)
학력
Northwestern University School of Law
J.D., 1995 (우등졸업)
Duke University
B.S., B.A., 1992
Majors: History, Psychology
Oxford University
Study Abroad, 1990
Majors: History, Psychology
자격 취득
변호사, 캘리포니아
변호사, 캘리포니아 중부 지방법원
Mr. Lawler's Articles at
-
Securities Law
Amgen Inc. v. Connecticut Retirement Plans & Trust Funds: Supreme Court Sides with Investors in Securities Fraud Class Action
April 17, 2013By Josh LawlerIn a 6-3 decision, the Supreme Court recently held that plaintiffs alleging 짠 10(b) securities fraud do not need to prove the materiality of a… More…
-
Securities Law
Gabelli v. SEC: Unanimous Supreme Court Rejects Extending Statute of Limitations in SEC Enforcement Actions
April 08, 2013By Josh LawlerThe Supreme Court recently upheld the five-year statute of limitations for SEC enforcement actions. In Gabelli v. SEC, No. 11-1274, (U.S. Feb. 27, 2013), the… More…
-
Securities Law
In re Rigel Pharmaceuticals, Inc.: Ninth Circuit Increases Difficulty for Investors to Sue Drug Companies Based on Clinical Trial Results
December 07, 2012By Josh Lawler and Kevin A. MalcomThe Ninth Circuit recently held that disagreement over the interpretation of clinical drug trial results was insufficient to plead falsity in a securities fraud claim.… More…
Subscribe to Email Updates
Subscribe to RSS Feed